Literature DB >> 18040659

Replication of the association between variants in WFS1 and risk of type 2 diabetes in European populations.

P W Franks1, O Rolandsson, S L Debenham, K A Fawcett, F Payne, C Dina, P Froguel, K L Mohlke, C Willer, T Olsson, N J Wareham, G Hallmans, I Barroso, M S Sandhu.   

Abstract

AIMS/HYPOTHESIS: Mutations at the gene encoding wolframin (WFS1) cause Wolfram syndrome, a rare neurological condition. Associations between single nucleotide polymorphisms (SNPs) at WFS1 and type 2 diabetes have recently been reported. Thus, our aim was to replicate those associations in a northern Swedish case-control study of type 2 diabetes. We also performed a meta-analysis of published and previously unpublished data from Sweden, Finland and France, to obtain updated summary effect estimates.
METHODS: Four WFS1 SNPs (rs10010131, rs6446482, rs752854 and rs734312 [H611R]) were genotyped in a type 2 diabetes case-control study (n = 1,296/1,412) of Swedish adults. Logistic regression was used to assess the association between each WFS1 SNP and type 2 diabetes, following adjustment for age, sex and BMI. We then performed a meta-analysis of 11 studies of type 2 diabetes, comprising up to 14,139 patients and 16,109 controls, to obtain a summary effect estimate for the WFS1 variants.
RESULTS: In the northern Swedish study, the minor allele at rs752854 was associated with reduced type 2 diabetes risk [odds ratio (OR) 0.85, 95% CI 0.75-0.96, p=0.010]. Borderline statistical associations were observed for the remaining SNPs. The meta-analysis of the four independent replication studies for SNP rs10010131 and correlated variants showed evidence for statistical association (OR 0.87, 95% CI 0.82-0.93, p=4.5 x 10(-5)). In an updated meta-analysis of all 11 studies, strong evidence of statistical association was also observed (OR 0.89, 95% CI 0.86-0.92; p=4.9 x 10(-11)). CONCLUSIONS/
INTERPRETATION: In this study of WFS1 variants and type 2 diabetes risk, we have replicated the previously reported associations between SNPs at this locus and the risk of type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18040659      PMCID: PMC2670195          DOI: 10.1007/s00125-007-0887-6

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  13 in total

1.  High-throughput genotyping with single nucleotide polymorphisms.

Authors:  K Ranade; M S Chang; C T Ting; D Pei; C F Hsiao; M Olivier; R Pesich; J Hebert; Y D Chen; V J Dzau; D Curb; R Olshen; N Risch; D R Cox; D Botstein
Journal:  Genome Res       Date:  2001-07       Impact factor: 9.043

2.  WFS1 is a novel component of the unfolded protein response and maintains homeostasis of the endoplasmic reticulum in pancreatic beta-cells.

Authors:  Sonya G Fonseca; Mariko Fukuma; Kathryn L Lipson; Linh X Nguyen; Jenny R Allen; Yoshitomo Oka; Fumihiko Urano
Journal:  J Biol Chem       Date:  2005-09-29       Impact factor: 5.157

3.  WFS1 (Wolfram syndrome 1) gene product: predominant subcellular localization to endoplasmic reticulum in cultured cells and neuronal expression in rat brain.

Authors:  K Takeda; H Inoue; Y Tanizawa; Y Matsuzaki; J Oba; Y Watanabe; K Shinoda; Y Oka
Journal:  Hum Mol Genet       Date:  2001-03-01       Impact factor: 6.150

4.  Cardiovascular disease and diabetes in the Northern Sweden Health and Disease Study Cohort - evaluation of risk factors and their interactions.

Authors:  Göran Hallmans; Asa Agren; Gerd Johansson; Anders Johansson; Birgitta Stegmayr; Jan-Håkan Jansson; Bernt Lindahl; Olle Rolandsson; Stefan Söderberg; Mats Nilsson; Ingegerd Johansson; Lars Weinehall
Journal:  Scand J Public Health Suppl       Date:  2003       Impact factor: 3.021

5.  Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.

Authors:  Richa Saxena; Benjamin F Voight; Valeriya Lyssenko; Noël P Burtt; Paul I W de Bakker; Hong Chen; Jeffrey J Roix; Sekar Kathiresan; Joel N Hirschhorn; Mark J Daly; Thomas E Hughes; Leif Groop; David Altshuler; Peter Almgren; Jose C Florez; Joanne Meyer; Kristin Ardlie; Kristina Bengtsson Boström; Bo Isomaa; Guillaume Lettre; Ulf Lindblad; Helen N Lyon; Olle Melander; Christopher Newton-Cheh; Peter Nilsson; Marju Orho-Melander; Lennart Råstam; Elizabeth K Speliotes; Marja-Riitta Taskinen; Tiinamaija Tuomi; Candace Guiducci; Anna Berglund; Joyce Carlson; Lauren Gianniny; Rachel Hackett; Liselotte Hall; Johan Holmkvist; Esa Laurila; Marketa Sjögren; Maria Sterner; Aarti Surti; Margareta Svensson; Malin Svensson; Ryan Tewhey; Brendan Blumenstiel; Melissa Parkin; Matthew Defelice; Rachel Barry; Wendy Brodeur; Jody Camarata; Nancy Chia; Mary Fava; John Gibbons; Bob Handsaker; Claire Healy; Kieu Nguyen; Casey Gates; Carrie Sougnez; Diane Gage; Marcia Nizzari; Stacey B Gabriel; Gung-Wei Chirn; Qicheng Ma; Hemang Parikh; Delwood Richardson; Darrell Ricke; Shaun Purcell
Journal:  Science       Date:  2007-04-26       Impact factor: 47.728

6.  Linkage of the gene for Wolfram syndrome to markers on the short arm of chromosome 4.

Authors:  M H Polymeropoulos; R G Swift; M Swift
Journal:  Nat Genet       Date:  1994-09       Impact factor: 38.330

7.  Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome.

Authors:  T G Barrett; S E Bundey; A F Macleod
Journal:  Lancet       Date:  1995-12-02       Impact factor: 79.321

8.  A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants.

Authors:  Laura J Scott; Karen L Mohlke; Lori L Bonnycastle; Cristen J Willer; Yun Li; William L Duren; Michael R Erdos; Heather M Stringham; Peter S Chines; Anne U Jackson; Ludmila Prokunina-Olsson; Chia-Jen Ding; Amy J Swift; Narisu Narisu; Tianle Hu; Randall Pruim; Rui Xiao; Xiao-Yi Li; Karen N Conneely; Nancy L Riebow; Andrew G Sprau; Maurine Tong; Peggy P White; Kurt N Hetrick; Michael W Barnhart; Craig W Bark; Janet L Goldstein; Lee Watkins; Fang Xiang; Jouko Saramies; Thomas A Buchanan; Richard M Watanabe; Timo T Valle; Leena Kinnunen; Gonçalo R Abecasis; Elizabeth W Pugh; Kimberly F Doheny; Richard N Bergman; Jaakko Tuomilehto; Francis S Collins; Michael Boehnke
Journal:  Science       Date:  2007-04-26       Impact factor: 47.728

9.  A variant in CDKAL1 influences insulin response and risk of type 2 diabetes.

Authors:  Valgerdur Steinthorsdottir; Gudmar Thorleifsson; Inga Reynisdottir; Rafn Benediktsson; Thorbjorg Jonsdottir; G Bragi Walters; Unnur Styrkarsdottir; Solveig Gretarsdottir; Valur Emilsson; Shyamali Ghosh; Adam Baker; Steinunn Snorradottir; Hjordis Bjarnason; Maggie C Y Ng; Torben Hansen; Yu Bagger; Robert L Wilensky; Muredach P Reilly; Adebowale Adeyemo; Yuanxiu Chen; Jie Zhou; Vilmundur Gudnason; Guanjie Chen; Hanxia Huang; Kerrie Lashley; Ayo Doumatey; Wing-Yee So; Ronald C Y Ma; Gitte Andersen; Knut Borch-Johnsen; Torben Jorgensen; Jana V van Vliet-Ostaptchouk; Marten H Hofker; Cisca Wijmenga; Claus Christiansen; Daniel J Rader; Charles Rotimi; Mark Gurney; Juliana C N Chan; Oluf Pedersen; Gunnar Sigurdsson; Jeffrey R Gulcher; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  Nat Genet       Date:  2007-04-26       Impact factor: 38.330

10.  Common variants in WFS1 confer risk of type 2 diabetes.

Authors:  Manjinder S Sandhu; Michael N Weedon; Katherine A Fawcett; Jon Wasson; Sally L Debenham; Allan Daly; Hana Lango; Timothy M Frayling; Rosalind J Neumann; Richard Sherva; Ilana Blech; Paul D Pharoah; Colin N A Palmer; Charlotte Kimber; Roger Tavendale; Andrew D Morris; Mark I McCarthy; Mark Walker; Graham Hitman; Benjamin Glaser; M Alan Permutt; Andrew T Hattersley; Nicholas J Wareham; Inês Barroso
Journal:  Nat Genet       Date:  2007-07-01       Impact factor: 38.330

View more
  51 in total

1.  Gene-Lifestyle Interactions in Complex Diseases: Design and Description of the GLACIER and VIKING Studies.

Authors:  Azra Kurbasic; Alaitz Poveda; Yan Chen; Asa Agren; Elisabeth Engberg; Frank B Hu; Ingegerd Johansson; Ines Barroso; Anders Brändström; Göran Hallmans; Frida Renström; Paul W Franks
Journal:  Curr Nutr Rep       Date:  2014-12-01

2.  Candidate gene studies reveal that the WFS1 gene joins the expanding list of novel type 2 diabetes genes.

Authors:  J Wasson; M A Permutt
Journal:  Diabetologia       Date:  2008-01-15       Impact factor: 10.122

3.  Genetics of type 2 diabetes.

Authors:  Omar Ali
Journal:  World J Diabetes       Date:  2013-08-15

Review 4.  Clinical review: the genetics of type 2 diabetes: a realistic appraisal in 2008.

Authors:  Jose C Florez
Journal:  J Clin Endocrinol Metab       Date:  2008-09-09       Impact factor: 5.958

Review 5.  Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes?

Authors:  J C Florez
Journal:  Diabetologia       Date:  2008-05-27       Impact factor: 10.122

Review 6.  Endoplasmic reticulum stress in beta-cells and development of diabetes.

Authors:  Sonya G Fonseca; Mark Burcin; Jesper Gromada; Fumihiko Urano
Journal:  Curr Opin Pharmacol       Date:  2009-08-06       Impact factor: 5.547

7.  Replication of 13 genome-wide association (GWA)-validated risk variants for type 2 diabetes in Pakistani populations.

Authors:  S D Rees; M Z I Hydrie; A S Shera; S Kumar; J P O'Hare; A H Barnett; A Basit; M A Kelly
Journal:  Diabetologia       Date:  2011-02-25       Impact factor: 10.122

Review 8.  Type 2 diabetes: new genes, new understanding.

Authors:  Inga Prokopenko; Mark I McCarthy; Cecilia M Lindgren
Journal:  Trends Genet       Date:  2008-10-25       Impact factor: 11.639

9.  Impact of polymorphisms in WFS1 on prediabetic phenotypes in a population-based sample of middle-aged people with normal and abnormal glucose regulation.

Authors:  T Sparsø; G Andersen; A Albrechtsen; T Jørgensen; K Borch-Johnsen; A Sandbaek; T Lauritzen; J Wasson; M A Permutt; B Glaser; S Madsbad; O Pedersen; T Hansen
Journal:  Diabetologia       Date:  2008-06-21       Impact factor: 10.122

Review 10.  The role of the unfolded protein response in diabetes mellitus.

Authors:  Takao Iwawaki; Daisuke Oikawa
Journal:  Semin Immunopathol       Date:  2013-03-26       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.